Articles published by Johnson & Johnson
Johnson & Johnson Names Eugene A. Woods, Chief Executive Officer of Advocate Health, to its Board of Directors
November 30, 2023
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
Johnson & Johnson to Host Enterprise Business Review
November 16, 2023
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
Johnson & Johnson Reports Q3 2023 Results
October 17, 2023
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
September 18, 2023
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
Johnson & Johnson Marks New Era as Global Healthcare Company With Updated Visual Identity
September 14, 2023
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue Separation
August 30, 2023
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
August 22, 2023
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
From Johnson & Johnson
Via Business Wire
Johnson & Johnson to Participate in the 2023 Wells Fargo Securities Healthcare Conference
August 07, 2023
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
From Johnson & Johnson
Via Business Wire
Johnson & Johnson Reports Q2 2023 Results
July 20, 2023
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference
May 10, 2023
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
Johnson & Johnson and Kenvue Announce Pricing of Upsized Kenvue Inc. Initial Public Offering
May 03, 2023
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Bernstein 39th Annual Strategic Decisions Conference
April 25, 2023
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
Johnson & Johnson Announces Dividend Increase of 5.3%
April 18, 2023
From Johnson & Johnson
Via Business Wire
Johnson & Johnson Reports Q1 2023 Results
April 18, 2023
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
Janssen Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Published in Nature
March 15, 2023
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
Johnson & Johnson Announces Pricing of $7.75 Billion of Senior Notes Issued by Kenvue Inc.
March 08, 2023
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
Johnson & Johnson Names Paula A. Johnson, President of Wellesley College, to its Board of Directors
February 14, 2023
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.